Quest Diagnostics 2000 Annual Report Download - page 107

Investor Information
Corporate Headquarters
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
Common Stock
Shares in Quest Diagnostics Incorporated
(ticker symbol: “DGX”) are listed on the
New York Stock Exchange. Options on
Quest Diagnostics shares are traded on the
Chicago Board Options Exchange.
Quest Diagnostics has not declared any
dividends on common stock.
Annual Meeting
The annual meeting of shareholders
is scheduled to be held on May 8, 2001,
at the Waldorf-Astoria Hotel in New York City,
at 10:00 A.M. A Proxy statement and Annual
Report were mailed to shareholders of record
as of March 19, 2001.
Additional Information
Address all inquiries to:
Investor Relations Department
Quest Diagnostics Incorporated
One Malcolm Avenue
Teterboro, New Jersey 07608
[phone]
[email protected]
Annual Report on Form 10-K
A copy of the Quest Diagnostics 2000 Annual
Report on Form 10-K, filed with the Securities
and Exchange Commission, is contained in this
Annual Report. Additional copies are available
without charge by contacting the Investor
Relations Department.
Internet Access
Corporate news releases, our Annual Report,
Forms 10-K and 10-Q and other information
about the company are available through the
Quest Diagnostics web site on the Internet:
www.questdiagnostics.com
Transfer Agent and Registrar
Computershare Investor Services
311 West Monroe Street
Chicago, Illinois 60606
[phone]
Report change of address
to Computershare at the above address.
“Safe Harbor” Statement under
the Private Securities Litigation Reform
Act of 1995
The statements in this Annual Report which are
not historical facts or information are forward-
looking statements. These forward-looking
statements involve risks and uncertainties that
could cause the outcome to be materially
different. Certain of these risks and uncertainties
are listed in the 2000 Annual Report on Form
10-K. These risks and uncertainties include
heightened competition, impact of changes in
payer mix, adverse actions by governmental
and other third-party payers, impact upon
collection rates or general or administrative
expenses resulting from compliance with
Medicare administrative policies, inability to
efficiently integrate acquired clinical laboratory
businesses, adverse results from pending
governmental investigations, reduction in tests
ordered by existing customers, material
increases in premiums for insurance coverage,
denial of licensure, computer or other system
failures, development of technologies that
substantially alter the practice of medicine, and
changes in interest rates.
Compliance
Quest Diagnostics is committed to the highest
ethical standards and compliance with all
applicable laws and regulations that govern its
business operations, including those that apply
to reimbursement for testing under the federal
Medicare and Medicaid programs. Quest
Diagnostics requires that all employees abide
by these laws, rules and regulations and
provides annual compliance training for all
employees. Quest Diagnostics is committed to
protecting the health and safety of its employees
as well as the environmental resources of the
communities in which it operates.
Privacy Statement
Quest Diagnostics is committed to protecting
the confidentiality of individuals’ private labora-
tory test results and other personal information.
We remain dedicated to full compliance with all
applicable federal, state and local laws and
regulations regarding the use and disclosure of
such information. For more information about
our privacy practices, please visit our web site
at www.questdiagnostics.com or send a
message to: [email protected] or
write to: Data Privacy and Security Officer,
Quest Diagnostics, One Malcolm Avenue,
Teterboro, NJ 07608.
Diversity
Quest Diagnostics is an Equal Employment
Opportunity and Affirmative Action employer
committed to creating and maintaining a
diverse work force. The company recruits,
hires, trains, develops, and promotes individuals
for all positions regardless of race, gender,
age, religion, national origin, sexual orientation,
disability, or status as a disabled veteran or
Vietnam era veteran.
reach!
Our national volunteer program, called reach!
(remember every act can help), is employee-
driven and encourages everyone at Quest
Diagnostics to contribute to the communities
in which they live and work, thereby helping to
improve the lives of those who use our services
every day. Quest Diagnostics, through the
reach! program, is a National Supporter
of the Juvenile Diabetes Research Foundation
and supports numerous other charitable
organizations throughout the United States.
Trademarks
Quest Diagnostics, Quest, and the Sun-Q
symbol are registered trademarks of
Quest Diagnostics Incorporated. QuestDirect
and all other names and logos, unless
otherwise indicated, are trademarks of
Quest Diagnostics Incorporated.
SmithKline Beecham Clinical Laboratories,
SmithKline Beecham, SBCL, SB and
the associated logo are trademarks of the
GlaxoSmithKline group of companies and
have been used under license.
ThinPrep® Pap Test™ is a registered trademark
of Cytyc Corporation.
HercepTest™ is a trademark of Genentech, Inc.
licensed to DAKO.
Neither this report nor any statement
contained herein is furnished in connection with
any offering of securities or for the purpose of
promoting or influencing the sale of securities.
©2001 Quest Diagnostics Incorporated.
All rights reserved.
Design: INC DESIGN, incdesign.com
This book is printed on recycled paper.